Advertisement
Screener

GUIDED THERAPEUTICS, INC. (GTHP) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1.4 / 5 stars · 17/59 Roast Me

GUIDED THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

GUIDED THERAPEUTICS, INC. (GTHP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 625.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13

  • GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
  • GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 625.00K shares.
  • GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares.
  • GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 0.00 shares.
  • GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 625.00K shares, a 14.68% increase from fiscal 2024.
  • GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 545.00K shares, a 46.83% decline from fiscal 2023.
  • GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.02M shares.
  • GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 4.48M shares, a 148.77% increase from fiscal 2020.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2026-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
625.00K shares
10-Q · filed 2026-08-13
2026-03-31625.00K shares
10-Q · filed 2026-05-15
2025-12-31625.00K shares
10-K · filed 2026-03-31
2025-06-30625.00K shares
10-Q · filed 2026-08-13
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
545.00K shares
10-K · filed 2026-03-31
2024-09-30545.00K shares
10-Q · filed 2024-11-14
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
0.00 shares
derived: sum of 2 quarters · filed 2025-03-31
0.00 shares
derived: sum of 3 quarters · filed 2025-03-31
1.02M shares
10-K · filed 2025-03-31
2023-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
0.00 shares
derived: sum of 2 quarters · filed 2024-11-14
1.02M shares
10-Q · filed 2024-11-14
2023-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
1.02M shares
10-Q · filed 2024-08-14
2023-03-311.02M shares
10-Q · filed 2024-05-14
2022-03-31650.00K shares
10-Q · filed 2022-05-16
2021-12-314.48M shares
10-K · filed 2022-03-30
2021-06-301.80M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-18
1.82M shares
10-Q · filed 2021-08-18
1.82M shares
derived: sum of 3 quarters · filed 2021-08-18
2021-03-3125.00K shares
10-Q · filed 2021-05-21
25.00K shares
derived: sum of 2 quarters · filed 2021-05-21
2020-12-310.00 shares
derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-04-07
1.80M shares
10-K · filed 2021-04-07
2020-09-301.80M shares
10-Q/A · filed 2020-11-05
2020-07-141.80M shares
10-Q · filed 2021-08-18
2019-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-20
0.00 shares
derived: sum of 2 quarters · filed 2020-04-20
0.00 shares
derived: sum of 3 quarters · filed 2020-04-20
650.14K shares
10-K · filed 2020-04-20
2019-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-09
0.00 shares
derived: sum of 2 quarters · filed 2020-03-09
650.14K shares
10-Q · filed 2020-03-09
2019-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-11
650.14K shares
10-Q · filed 2020-02-11
2019-03-31650.14K shares
10-Q · filed 2019-07-11
2018-12-312.61M shares
10-K · filed 2019-05-08